The -842G/C Polymorphisms of PIN1 Contributes to Cancer Risk: A Meta-Analysis of 10 Case-Control Studies

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Xu, Hui Rong ^a   Xu, Zhong Fa ^a   Sun, Yan Lai ^a   Han, Jian Jun ^a   Li, Zeng Jun ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDYLPROLYL ISOMERASE PIN1;

ARTICLE; ASIAN; CANCER CLASSIFICATION; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PIN1 GENE; RISK REDUCTION; WILD TYPE;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; PEPTIDYLPROLYL ISOMERASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84883195301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071516     Document Type: Article

References (44)

1. Blume-Jensen P, Hunter T, (2001) Oncogenic kinase signalling. Nature 411: 355-365.
2. Lu KP, (2003) Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 4: 175-180.
3. Lu KP, (2004) Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem Sci 29: 200-209.
4. Lu KP, Zhou XZ, (2007) The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8: 904-916.
5. Galat A, (2003) Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions. Curr Top Med Chem 3: 1315-1347.
6. Lu KP, Liou YC, Zhou XZ, (2002) Pinning down proline-directed phosphorylation signaling. Trends Cell Biol 12: 164-172.
7. Yeh ES, Means AR, (2007) PIN1, the cell cycle and cancer. Nat Rev Cancer 7: 381-388.
8. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, et al. (2004) Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 164: 1727-1737.
9. Ryo A, Liou YC, Wulf G, Nakamura M, Lee SW, et al. (2002) PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 22: 5281-5295.
10. Ayala G, Wang D, Wulf G, Frolov A, Li R, et al. (2003) The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 63: 6244-6251.
11. Miyashita H, Mori S, Motegi K, Fukumoto M, Uchida T, (2003) Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol Rep 10: 455-461.
12. Ryo A, Nakamura M, Wulf G, Liou YC, Lu KP, (2001) Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 3: 793-801.
13. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, et al. (2001) Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 20: 3459-3472.
14. Han CH, Lu J, Wei Q, Bondy ML, Brewster AM, et al. (2010) The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. Breast Cancer Res Treat 122: 243-249.
15. Naidu R, Har YC, Taib NA, (2011) Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G>C) and -667(T>C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters. Scand J Clin Lab Invest 71: 500-506.
16. Lu J, Yang L, Zhao H, Liu B, Li Y, et al. (2011) The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations. Hum Mutat 32: 1299-1308.
17. You Y, Deng J, Zheng J, Jiang L, Li N, et al. (2013) Functional polymorphisms in PIN1 promoter and esophageal carcinoma susceptibility in Chinese population. Mol Biol Rep 40: 829-838.
18. Segat L, Milanese M, Crovella S, (2007) Pin1 promoter polymorphisms in hepatocellular carcinoma patients. Gastroenterology 132: 2618-2619; author reply 2619-2620.
19. Lu Y, Huang GL, Pu XX, He YX, Li BB, et al. (2012) Association between PIN1 promoter polymorphisms and risk of nasopharyngeal carcinoma. Mol Biol Rep.
20. Cao WP, Ruan HY, Tang HL, (2012) Association between polymophisms in prolyl isomerase Pin1 and the risk for laryngeal squamous cell carcinoma. Jiangsu Med J May 2012, Vol, No 38: 1067-1070.
21. Lu J, Hu Z, Wei S, Wang LE, Liu Z, et al. (2009) A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis 30: 1717-1721.
22. Guo J, Jin M, Zhang M, Chen K, (2012) A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies. PLoS One 7: e30585.
23. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
24. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
25. Whitehead A, Whitehead J, (1991) A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 10: 1665-1677.
26. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
27. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
28. Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, et al. (2002) The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419: 853-857.
29. Zheng H, You H, Zhou XZ, Murray SA, Uchida T, et al. (2002) The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419: 849-853.
30. Mantovani F, Piazza S, Gostissa M, Strano S, Zacchi P, et al. (2004) Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol Cell 14: 625-636.
31. Chen SY, Wulf G, Zhou XZ, Rubin MA, Lu KP, et al. (2006) Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction. Mol Cell Biol 26: 929-939.
32. Li H, Wang S, Zhu T, Zhou J, Xu Q, et al. (2006) Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression. Oncol Rep 16: 491-496.
33. Liou YC, Ryo A, Huang HK, Lu PJ, Bronson R, et al. (2002) Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci U S A 99: 1335-1340.
34. Nakashima M, Meirmanov S, Naruke Y, Kondo H, Saenko V, et al. (2004) Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression. J Pathol 202: 446-455.
35. Yeh ES, Lew BO, Means AR, (2006) The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J Biol Chem 281: 241-251.
36. Dougherty MK, Muller J, Ritt DA, Zhou M, Zhou XZ, et al. (2005) Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell 17: 215-224.
37. Lam PB, Burga LN, Wu BP, Hofstatter EW, Lu KP, et al. (2008) Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability. Mol Cancer 7: 91.
38. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, et al. (2004) A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6: 308-318.
39. Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, et al. (2009) The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 28: 3735-3745.
40. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, et al. (2003) Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63: 196-206.
41. Fukuchi M, Fukai Y, Kimura H, Sohda M, Miyazaki T, et al. (2006) Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int J Oncol 29: 329-334.
42. Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, et al. (2012) A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep 39: 269-275.
43. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K, (2002) A comprehensive review of genetic association studies. Genet Med 4: 45-61.
44. Dick DM, (2011) Gene-environment interaction in psychological traits and disorders. Annu Rev Clin Psychol 7: 383-409.